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Background. Influenza in children who reside in tropical and subtropical regions has until recently been regarded as insignif-
icant. However, new evidence suggests that it significantly impacts hospitalization and promotes secondary bacterial coinfections. 
Ethiopia is situated in a subtropical area where influenza viruses are likely to circulate year round.
Methods. Clinical data were recorded in a cohort of 103 healthy preschool children recruited in Addis Ababa, Ethiopia. Humoral 
and cellular immune responses to influenza virus were determined by hemagglutination inhibition (HI) and interferon-γ enzyme-
linked immunospot assays.
Results. Ninety-six percent of the children (2–5 years old) had pre-existing HI antibody responses to 1 or more of the circulating 
influenza A subtypes, H1N1 (51%), H3N2 (86%), or influenza B (51%) strains. At the age of 4, all children had been infected with 
at least 1 strain, and 75% had been infected with 2–4 different viral strains. CD4+ and CD8+ T-cell responses against conserved viral 
antigens increased with repeated exposures, indicating boosting of cross-reactive cellular immunity. Malnutrition did not seem to 
affect these immune responses to influenza.
Conclusions. Influenza is highly prevalent among children in this area of Ethiopia. Due to the risk of secondary bacterial pneu-
monia, increased influenza awareness might benefit child health.
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Influenza is responsible for 3 to 5 million cases of severe illness 
and approximately 250 000 to 500 000 deaths yearly [1]. In addi-
tion to the seasonal circulating strains, new pandemic strains 
arise occasionally, with 3 pandemics occurring in the 20th cen-
tury [2], and most recently, the 2009 H1N1 pandemic [3]. In 
temperate regions where influenza has clear seasonality, most 
evident during the winter months, influenza viruses infect 
approximately 20% of the population. Of those infected, 75% 
represent subclinical infections [4]. In tropical and subtropical 
regions, however, influenza exposure is believed to occur more 
or less throughout the year [1, 5, 6]. The impact of influenza on 
morbidity in these regions is less characterized and has previ-
ously been considered as insignificant [6], although studies from 
Hong Kong, another subtropical city, show that influenza is an 
important reason for hospitalization among children, with rates 
exceeding 10-fold those reported for temperate regions [7].
Severe clinical outcomes of influenza may be due to sec-
ondary bacterial infections; therefore, hospitalizations and 
deaths may not be attributed directly to influenza. In fact, 
influenza has been significantly associated with superinfections 
due to Streptococcus pneumoniae, Haemophilus influenzae, 
Staphylococcus aureus, and Mycobacterium tuberculosis, thereby 
leading to increased mortality [8–10]. Nasopharyngeal coloni-
zation with S pneumoniae in children with influenza is linked 
to invasive pneumococcal pneumonia [11], which may explain 
why pneumonia is the number one cause of death in children 
under 5 worldwide [12–14].
Antibody-mediated protection against influenza is conferred 
mainly through the dominant neutralizing epitopes, which 
are found in the major surface glycoprotein hemagglutinin. 
In contrast, cell-mediated immunity (CMI) is mainly directed 
against the conserved internal antigens of the virus and may 
thus be able to cross-protect against heterologous viral strains. 
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Evidence supporting the role of CMI in influenza viral clear-
ance and host survival is well documented in mouse models 
and increasingly so in humans [15–18]. Cross-subtype reactive 
CD8+ T cell responses may clear virus infection even in people 
who lack virus-specific antibodies [19, 20].
CD4+ T cells play an important role by providing help to B 
cells for antibody production and directing effector functions 
of CD8+ T cells. In recent studies, it has been shown that CD4+ 
T cells act not only by orchestrating the immune response, but 
also by directly killing infected cells. Furthermore, pre-existing 
influenza-specific CD4+ and CD8+ T cells have been associated 
with decreased viral shedding and reduced severity of illness 
[17, 18, 20].
In this study, we have analyzed both the humoral and cellu-
lar immunity to influenza in a cohort of healthy children under 
5  years old and living in the Kolfe Kerano subcity of Addis 
Ababa in Ethiopia, an area with a subtropical climate. We found 
that a high percentage of children had been exposed to multi-




The study was approved by both the Regional Committee for 
Medical and Health Research Ethics South East, Norway (ref-
erence number 2012/2183) and AHRI/ALERT and National 
Health Research Ethics Review Committee of Ethiopia (refer-
ence numbers PO32/13 and 3.10/447/06). Written informed 
consent was obtained from the parents or next of kin of all 
participants. The children were recruited between March and 
September 2014. One hundred three children, aged 2–5 (23–
60  months) years, were selected using a systematic sampling 
procedure from all the healthy children residing in Woreda 01, 
Kolfe Kerano subcity of Addis Ababa: chronically ill childred 
or children who tested positive for human immunodeficiency 
virus were excluded. They were unvaccinated against influ-
enza or S pneumoniae. At inclusion, a structured questionnaire, 
which collected information about weight, height, medical his-
tory, and socio-demographic parameters, was completed for 
each volunteer, and a blood sample was obtained.
Sample Collection
Venous blood (up to 9 mL) was collected in acid citrate dextrose 
tubes (BD Vacutainer). Peripheral blood mononuclear cells 
(PBMC) (n = 95 children with enough cells for analysis) and 
plasma (n = 103) were isolated by Ficoll-Paque density gradient 
centrifugation (Ficoll-Paque Premium 1.077; GE Healthcare) 
using SepMate 50-mL tubes (Stemcell Technologies) follow-
ing the manufacturer’s instructions. Cells were cryopreserved 
at −150°C in 25% fetal calf serum/10% dimethyl sulfoxide 
(DMSO)/65% AIM-V media (Gibco; Thermo Fisher Scientific, 
Waltham, MA), and plasma was stored at −80°C until used.
Peptides and Viruses
Peptides containing an optimal combination of human leu-
kocyte antigen (HLA) class I- and II-restricted T cell epitopes 
from viral proteins conserved among influenza strains circu-
lating between 1934 and 2009 were selected and chemically 
synthesized by Mimotopes (Clayton, Australia). The pep-
tides were selected according to prevalence, conservancy, and 
HLA supertype coverage [21]. This approach circumvents 
the need for individual HLA typing. Influenza-specific CD4 
and CD8 conserved peptides were pooled and used as anti-
gen stimulants in interferon (IFN)γ enzyme-linked immu-
nospot (ELISpot) assays [21], in addition to stimulation 
with whole inactivated viruses (A/California/7/2009(H1N1)
pdm09 and A/Brisbane/10/2007(H3N2) [22]. The inactivated 
influenza antigens A/California/7/2009(H1N1)pdm09, A/
Perth/16/2009(H3N2), A/Victoria/361/2011-like(H3N2), B/
Brisbane/60/2008, and B/ Wisconsin/1/2010 (Influenza Reagent 
Resources, Centers for Disease Control and Prevention) were 
used in hemagglutination inhibition (HI) assays.
Hemagglutination Inhibition Assay
All plasma samples were treated with receptor-destroying 
enzyme (RDE) (Denka Seiken, Tokyo, Japan) and heat inacti-
vated before use. The HI assay was performed in duplicate for 
all RDE-treated plasma samples at the same time using 0.7% 
turkey red blood cells with 8 hemagglutinating units (HAU) 
of β-propiolacetone-inactivated influenza A and ether-ex-
tracted influenza B strains, as previously described [23]. The HI 
antibody titer was determined as the reciprocal of the highest 
plasma dilution causing 50% inhibition of hemagglutination. 
Negative titers (<10) were assigned a value of 5 for calculation 
purposes. Intermediate values represent geometric mean titers 
of repeated testing.
Ex Vivo Interferon-γ Enzyme-Linked Immunospot Assay 
The influenza-specific IFNγ T cell responses were measured by 
ex vivo ELISpot assay according to the manufacturer’s instruc-
tions (CTL, Bonn, Germany) [21]. In short, 200 000 PBMC in 
AIM-V medium (Gibco) were added to each well in 96-well 
plates precoated with IFNγ antibodies. Antigenic stimulants 
used were as follows: negative control (0.28% DMSO in AIM-V 
to match the final DMSO concentration in each of the epitope 
libraries), positive control (5 µg/mL Concanavalin A), and CD4 
and CD8 epitope libraries (2 µg/mL final concentration per 
well of individual peptides in DMSO/AIM-V). In addition, 75 
HAU of whole inactivated viruses (A/California/7/2009(H1N1)
pdm09 and A/Brisbane/10/2007(H3N2)) were used as antigenic 
stimulants [22]. Plates were incubated for 20 hours at 37°C in a 
humidified incubator with 5% CO2 and developed the following 
day. The plates were read using a CTL S6 UltraV ImmunoSpot 
analyzer (Cellular Technology Limited, Shaker Heights, OH). 
Data were analyzed using Microsoft Excel and GraphPad Prism 
software (GraphPad Software, Inc.). Background values from 
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the negative control were subtracted from the values achieved 
after antigen stimulation. Two standard deviations (SD) above 
background were regarded as a positive response. Zero values 
were set to 1 for calculation purposes.
Statistics
Statistical analyses were performed by the Mann-Whitney U 
test or linear regression using either GraphPad Prism version 
5.04 or STATA version 13. P < .05 was considered significant.
RESULTS
Study Population
Of the 103 children included, 53% were female. The average 
age was 51 months, 39 of whom were <49 months old (only 
2 children were <36 months old), and 64 were ≥49 months of 
age. Figure 1 shows the distribution of girls and boys according 
to the World Health Organization (WHO) standard weight-for-
height growth curves for children 2–5 years old [24]. Most chil-
dren fell within the normal range, but 7 of the children (4 girls, 
and 3 boys) were underweight, i.e., fell below the 3rd percentile, 
suggesting malnutrition.
High Prevalence of Influenza Exposure in Preschool Children
Because no routine influenza surveillance occurs in Ethiopia, 
the influenza A  and B strains expected to have circulated 
between 2009 and 2014 were selected from the annual WHO 
reports and vaccine recommendations [25]. Using results from 
the HI assay, we found that 86% of the children had positive 
responses (HI ˃10) to the A/Perth/16/2009(H3N2) strain, and 
45% had positive responses to the A/H3N2/361/2011-like strain, 
whereas 50% were positive for the A/California/7/2009(H1N1)
pdm09. With respect to the B strains, 37% were posi-
tive for B/Brisbane/60/2008, and 19% were positive for B/
Wisconsin/1/2010 (Figure 2; Supplementary Table 1).
Ninety-six percent of the children had antibodies against 
influenza, and the number of influenza A  and B strain expo-
sures correlated with increasing age (Figure  3). Only 4% of 
the children lacked antibodies to any of the viral strains, and 
these children were among the younger ones. On the other 
hand, approximately 5% of the children displayed evidence 
of a previous exposure to all 5 viruses tested. Children at or 
above 49  months of age were significantly more frequently 
exposed to the A/California/7/2009(H1N1)pdm09 and A/
Victoria/361/2011-like(H3N2) strains of viruses than those 
below 49 months (Supplementary Table 1).
Repeated Influenza Infections Boosts Cross-Reactive CD4+ and CD8+ T 
Cell Responses
Robust Th1 responses were observed after stimulation with the 
inactivated whole viruses, with 35% of the children displaying 
positive responses, ie, 2 SD above background, to the H1N1 and 
57% to the H3N2 viruses, respectively. A small but statistically 
significant increase in the mean IFNγ response towards the 
H3N2 virus was seen (Figure 4A).
Compared with whole virus stimulation, a considerable 
lower response was detected when using individual peptide 
pools as antigens (Figure 4). However, there was a positive 
correlation between T cell responses to peptide epitopes from 
conserved influenza antigens and whole virus used in the 
ELISpot assays. This correlation was present for both CD4+ and 
CD8+ T cell responses (data not shown). The number of CD4+ 




































Figure 1. Study demographics. Weight-for-height percentiles in preschool (2–5 years old) children (n = 53 girls and 50 boys), living in Addis Ababa, Ethiopia, using World 














Figure  2. Humoral immune responses to influenza. Hemagglutination inhibi-
tion (HI) antibody titers to influenza A/H1N1/7/California/2009 (H1N1/pdm09), 
A/Perth/16/2009(H3N2) (H3N2/Per2009), A/H3N2/361/Victoria/2011-like (H3N2/
Vic2011), B/Brisbane/60/2008 (B/Bris2009), and B/Wisconsin/1/2010 (B/Wis2010) 
viruses, in plasma from 103 preschool (2–5 years old) children living in Addis Ababa, 
Ethiopia. Hemagglutination inhibition values <10 were considered negative and 
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those recognizing external antigens, although not significantly 
(Figure 4B). With respect to CD8 epitopes, the number of T 
cells recognizing internal and external antigens were approxi-
mately equal (Figure 4C).
The level of IFNγ expressing T cells recognizing internal 
epitope sets increased with number of viral exposures (Figure 
5A and B). After 1 exposure, the IFNγ response to the internal 
and external CD4 epitope sets were equal, but after 3 exposures, 
the response to the internal, conserved epitope sets were sig-
nificantly boosted above the response level detected with the 
external epitope set (Figure 5A). On the other hand, elevated 
CD8+ T cell responses were found for both internal and exter-
nal antigens after 3 exposures, but this difference was significant 
only for external antigens.
Children who were underweight had immune responses in 
the same range as in the normal weight children. It is interest-
ing to note that the underweight children had CMI responses 
against both H1 and H3 viruses (Supplementary Figure 1B and 
D) but only humoral responses against the H3 virus (except for 
1) (Supplementary Figure 1A and C), indicating that these chil-
dren were previously exposed only to an H3 virus. We found 
no correlation between humoral (HI titer) and cellular immune 
responses (IFNγ ELISpot) in the children.
DISCUSSION
In this study, we examined immune responses to influenza 
viruses in healthy preschool children living in a city with a sub-
tropical climate, allowing insight into the range of influenza 
incidence in the area and the associated disease burden it may 
cause. We found that almost all of the children in our study had 
antibodies against at least 1 influenza strain, which may not 
be completely unexpected, when compared with the seasonal 
infection rate of 20% in temperate regions [4]. However, the fact 
that 67% of the children had antibodies specific to 2–4 differ-
ent influenza virus isolates, and 5% had antibodies to 5 differ-
ent influenza strains, was surprising. Almost all of the children 
in our study were infected during the 2-year period between 
the age of 3 and 5. A  large proportion of these children were 
infected with more than 1 influenza strain annually.
Eighty-six percent of the children tested positive for influenza 
A/H3N2/16/Perth/2009; this was equally frequent among the 
older and younger children, and it is therefore likely that this 
strain had circulated throughout the whole period during our 
study. On the other hand, 64% of the older children had antibod-
ies to A/California/7/2009(H1N1)pdm09, compared with 28% 
of younger children, indicating that this strain was more preva-
lent during previous years. A similar pattern was observed with 
the A/H3N2/316/Victoria/2011-like and the B strains.
Correspondingly, 57% of the children developed influen-
za-specific IFNγ-secreting T cell responses to the H3N2 virus, as 
opposed to only 35% towards the H1N1 virus. Moreover, these 
children had cross-subtype CD4+ and CD8+ T cell responses to 
antigens that are highly conserved among influenza A strains, a 
finding that has recently been shown to correlate with protec-


















































Figure 4. Cellular immune responses to influenza. Cellular immune responses, measured as spot-forming units (SFU), indicating the number of interferon (IFN)γ-producing 
cells per million peripheral blood mononuclear cells (PBMC) from 95 preschool (2–5 years old) children living in Addis Ababa, Ethiopia, after stimulation with (A) whole 
inactivated influenza A/California/7/2009(H1N1)pdm09 or A/Brisbane/10/2007(H3N2) viruses or with (B) influenza-specific CD4 and (C) CD8 epitopes, derived from internal 





















Figure  3. Exposure frequency to influenza increases with age. Number of 
influenza A and B virus exposures relative to age among 103 preschool children 
living in Addis Ababa, Ethiopia, measured as detectable hemagglutination inhi-
bition antibody titers >10 to influenza A/California/7/2009(H1N1)pdm09, A/
Perth/16/2009(H3N2), A/Victoria/361/2011-like(H3N2), B/Brisbane/60/2008, and 
B/Wisconsin/1/2010 viruses, with linear regression values.
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20, 26]. Even low numbers of spot-forming units, as a measure 
of IFNγ-secreting T cell responses, have been linked to reduced 
viral shedding in symptomatic polymerase chain reaction-con-
firmed influenza disease [18].
In contrast to the antibody responses that are highly strain 
specific, repeated exposures to several influenza A strains 
resulted in boosting of both CD4+ and CD8+ T cell responses. 
This is due to the nature of the conserved antigens among 
different influenza strains, which may additionally boost 
memory T cells specific for previously encountered strains. 
It is in accordance with previous work showing that children 
develop virus-specific CD8+ T cell responses after infection, 
and boosting increases with age, likely correlating to the 
number of influenza virus exposures experienced [27, 28]. As 
shown previously [29], repeated exposures skewed the CD4+ 
responses from external towards internal antigens, suggest-
ing maturation of immune responses known to correlate with 
protection [17, 20]. However, the CD8+ responses measured 
in this study were not found to be skewed in this fashion, as 
repeated exposures increased responses against the external 
antigens. This difference may be explained by the formula-
tion of the CD8e peptide pool, because it consists of only 3 
peptides with 1 originating from the M2 extracellular region 
of the virus, a region highly conserved among influenza A 
viruses [30].
Among the underweight children in our study, only 1 had an 
HI titer against the A/California/7/2009(H1N1)pdm09 strain. 
Nevertheless, these same children reacted with T cell responses 
after stimulation with an H1N1 virus, a finding indicating pre-
vious infection with a different influenza A strain capable of 
inducing cross-subtype immune responses. In fact, 6 of 7 chil-
dren produced antibodies specific for a H3N2 strain. Thus, even 
the underweight children had the capacity of reacting with anti-
bodies as well as T cell responses against influenza.
CONCLUSIONS
Our unexpected finding, that several strains of influenza viruses 
may have infected the same preschool children living in a subtrop-
ical area of Ethiopia, is of major concern with regard to general 
health. Next-generation influenza vaccines, aimed at controlling 
the spread of viruses and reducing the severity of infections, 
should ideally be capable of inducing cross-protective immunity.
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